{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T11:35:58Z","timestamp":1791286558863,"version":"4.1.0"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2016,3,17]],"date-time":"2016-03-17T00:00:00Z","timestamp":1458172800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2016,3,17]],"date-time":"2016-03-17T00:00:00Z","timestamp":1458172800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Podocyte apoptosis is a major mechanism that leads to proteinuria in many chronic kidney diseases. However, the concert mechanisms that cause podocyte apoptosis in these kidney diseases are not fully understood. The Rho family of small GTPases has been shown to be required in maintaining podocyte structure and function. Recent studies have indicated that podocyte-specific deletion of Cdc42 <jats:italic>in vivo<\/jats:italic>, but not of RhoA or Rac1, leads to congenital nephrotic syndrome and glomerulosclerosis. However, the underlying cellular events in podocyte controlled by Cdc42 remain unclear. Here, we assessed the cellular mechanisms by which Cdc42 regulates podocyte apoptosis. We found that the expression of Cdc42 and its activity were significantly decreased in high glucose-, lipopolysaccharide- or adriamycin-injured podocytes. Reduced Cdc42 expression <jats:italic>in vitro<\/jats:italic> and <jats:italic>in vivo<\/jats:italic> by small interfering RNA and selective Cdc42 inhibitor ML-141, respectively, caused podocyte apoptosis and proteinuria. Our results further demonstrated that insufficient Cdc42 or Nwasp, its downstream effector, could decrease the mRNA and protein expression of YAP, which had been regarded as an anti-apoptosis protein in podocyte. Moreover, our data indicated that the loss of stress fibers caused by Cdc42\/Nwasp deficiency also decreased Yes-associated protein (YAP) mRNA and protein expression, and induced podocyte apoptosis. Podocyte apoptosis induced by Cdc42\/Nwasp\/stress fiber deficiency was significantly inhibited by overexpressing-active YAP. Thus, the Cdc42\/Nwasp\/stress fibers\/YAP signal pathway may potentially play an important role in regulating podocyte apoptosis. Maintaining necessary Cdc42 would be one potent way to prevent proteinuria kidney diseases.<\/jats:p>","DOI":"10.1038\/cddis.2016.51","type":"journal-article","created":{"date-parts":[[2016,3,17]],"date-time":"2016-03-17T13:47:02Z","timestamp":1458222422000},"page":"e2142-e2142","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":61,"title":["Cdc42 deficiency induces podocyte apoptosis by inhibiting the Nwasp\/stress fibers\/YAP pathway"],"prefix":"10.1038","volume":"7","author":[{"given":"Z","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Q","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Z","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"X","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Z","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"X","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,3,17]]},"reference":[{"key":"BFcddis201651_CR1","doi-asserted-by":"publisher","first-page":"1288","DOI":"10.1038\/nm.3313","volume":"19","author":"G Canaud","year":"2013","unstructured":"Canaud G, Bienaime F, Viau A, Treins C, Baron W, Nguyen C et al. AKT2 is essential to maintain podocyte viability and function during chronic kidney disease. Nat Med 2013; 19: 1288\u20131296.","journal-title":"Nat Med"},{"key":"BFcddis201651_CR2","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1016\/j.yexcr.2013.01.007","volume":"319","author":"R Li","year":"2013","unstructured":"Li R, Zhang L, Shi W, Zhang B, Liang X, Liu S et al. NFAT2 mediates high glucose-induced glomerular podocyte apoptosis through increased Bax expression. Exp Cell Res 2013; 319: 992\u20131000.","journal-title":"Exp Cell Res"},{"key":"BFcddis201651_CR3","doi-asserted-by":"publisher","first-page":"225","DOI":"10.2337\/diabetes.55.01.06.db05-0894","volume":"55","author":"K Susztak","year":"2006","unstructured":"Susztak K, Raff AC, Schiffer M, Bottinger EP . Glucose-induced reactive oxygen species cause apoptosis of podocytes and podocyte depletion at the onset of diabetic nephropathy. Diabetes 2006; 55: 225\u2013233.","journal-title":"Diabetes"},{"key":"BFcddis201651_CR4","doi-asserted-by":"publisher","first-page":"F1140","DOI":"10.1152\/ajprenal.00216.2009","volume":"298","author":"CB Marshall","year":"2010","unstructured":"Marshall CB, Krofft RD, Pippin JW, Shankland SJ . CDK inhibitor p21 is prosurvival in adriamycin-induced podocyte injury, in vitro and in vivo. Am J Physiol Renal Physiol 2010; 298: F1140\u2013F1151.","journal-title":"Am J Physiol Renal Physiol"},{"key":"BFcddis201651_CR5","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1038\/nature01148","volume":"420","author":"S Etienne-Manneville","year":"2002","unstructured":"Etienne-Manneville S, Hall A . Rho GTPases in cell biology. Nature 2002; 420: 629\u2013635.","journal-title":"Nature"},{"key":"BFcddis201651_CR6","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1146\/annurev.cellbio.21.020604.150721","volume":"21","author":"AB Jaffe","year":"2005","unstructured":"Jaffe AB, Hall A . Rho GTPases: biochemistry and biology. Annu Rev Cell Dev Biol 2005; 21: 247\u2013269.","journal-title":"Annu Rev Cell Dev Biol"},{"key":"BFcddis201651_CR7","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1139\/cjpp-2013-0135","volume":"91","author":"F Mouawad","year":"2013","unstructured":"Mouawad F, Tsui H, Takano T . Role of Rho-GTPases and their regulatory proteins in glomerular podocyte function. Can J Physiol Pharmacol 2013; 91: 773\u2013782.","journal-title":"Can J Physiol Pharmacol"},{"key":"BFcddis201651_CR8","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1146\/annurev-med-050311-163340","volume":"64","author":"J Reiser","year":"2013","unstructured":"Reiser J, Sever S . Podocyte biology and pathogenesis of kidney disease. Annu Rev Med 2013; 64: 357\u2013366.","journal-title":"Annu Rev Med"},{"key":"BFcddis201651_CR9","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1038\/ki.2011.472","volume":"81","author":"L Wang","year":"2012","unstructured":"Wang L, Ellis MJ, Gomez JA, Eisner W, Fennell W, Howell DN et al. Mechanisms of the proteinuria induced by Rho GTPases. Kidney Int 2012; 81: 1075\u20131085.","journal-title":"Kidney Int"},{"key":"BFcddis201651_CR10","doi-asserted-by":"publisher","first-page":"F1015","DOI":"10.1152\/ajprenal.00380.2011","volume":"303","author":"C Meyer-Schwesinger","year":"2012","unstructured":"Meyer-Schwesinger C, Dehde S, Sachs M, Mathey S, Arefi K, Gatzemeier S et al. Rho-kinase inhibition prevents proteinuria in immune-complex-mediated antipodocyte nephritis. Am J Physiol Renal Physiol 2012; 303: F1015\u2013F1025.","journal-title":"Am J Physiol Renal Physiol"},{"key":"BFcddis201651_CR11","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1681\/ASN.2011121206","volume":"23","author":"RP Scott","year":"2012","unstructured":"Scott RP, Hawley SP, Ruston J, Du J, Brakebusch C, Jones N et al. Podocyte-specific loss of Cdc42 leads to congenital nephropathy. J Am Soc Nephrol 2012; 23: 1149\u20131154.","journal-title":"J Am Soc Nephrol"},{"key":"BFcddis201651_CR12","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1038\/ki.2013.175","volume":"84","author":"SM Blattner","year":"2013","unstructured":"Blattner SM, Hodgin JB, Nishio M, Wylie SA, Saha J, Soofi AA et al. Divergent functions of the Rho GTPases Rac1 and Cdc42 in podocyte injury. Kidney Int 2013; 84: 920\u2013930.","journal-title":"Kidney Int"},{"key":"BFcddis201651_CR13","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/j.devcel.2010.09.011","volume":"19","author":"D Pan","year":"2010","unstructured":"Pan D . The hippo signaling pathway in development and cancer. Dev Cell 2010; 19: 491\u2013505.","journal-title":"Dev Cell"},{"key":"BFcddis201651_CR14","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/j.cell.2005.06.007","volume":"122","author":"J Huang","year":"2005","unstructured":"Huang J, Wu S, Barrera J, Matthews K, Pan D . The hippo signaling pathway coordinately regulates cell proliferation and apoptosis by inactivating Yorkie, the Drosophila homolog of YAP. Cell 2005; 122: 421\u2013434.","journal-title":"Cell"},{"key":"BFcddis201651_CR15","doi-asserted-by":"publisher","first-page":"3320","DOI":"10.1101\/gad.1726608","volume":"22","author":"X Cao","year":"2008","unstructured":"Cao X, Pfaff SL, Gage FH . YAP regulates neural progenitor cell number via the TEA domain transcription factor. Genes Dev 2008; 22: 3320\u20133334.","journal-title":"Genes Dev"},{"key":"BFcddis201651_CR16","doi-asserted-by":"publisher","first-page":"5496","DOI":"10.1074\/jbc.M709037200","volume":"283","author":"Y Hao","year":"2008","unstructured":"Hao Y, Chun A, Cheung K, Rashidi B, Yang X . Tumor suppressor LATS1 is a negative regulator of oncogene YAP. J Biol Chem 2008; 283: 5496\u20135509.","journal-title":"J Biol Chem"},{"key":"BFcddis201651_CR17","doi-asserted-by":"publisher","first-page":"2747","DOI":"10.1101\/gad.1602907","volume":"21","author":"B Zhao","year":"2007","unstructured":"Zhao B, Wei X, Li W, Udan RS, Yang Q, Kim J et al. Inactivation of YAP oncoprotein by the Hippo pathway is involved in cell contact inhibition and tissue growth control. Genes Dev 2007; 21: 2747\u20132761.","journal-title":"Genes Dev"},{"key":"BFcddis201651_CR18","doi-asserted-by":"publisher","first-page":"17057","DOI":"10.1074\/jbc.C113.457390","volume":"288","author":"KN Campbell","year":"2013","unstructured":"Campbell KN, Wong JS, Gupta R, Asanuma K, Sudol M, He JC et al. Yes-associated protein (YAP) promotes cell survival by inhibiting proapoptotic dendrin signaling. J Biol Chem 2013; 288: 17057\u201317062.","journal-title":"J Biol Chem"},{"key":"BFcddis201651_CR19","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1681\/ASN.2014090916","volume":"27","author":"M Schwartzman","year":"2015","unstructured":"Schwartzman M, Reginensi A, Wong JS, Basgen JM, Meliambro K, Nicholas SB et al. Podocyte-specific deletion of Yes-associated protein causes FSGS and progressive renal failure. J Am Soc Nephrol 2015; 27: 216\u2013226.","journal-title":"J Am Soc Nephrol"},{"key":"BFcddis201651_CR20","doi-asserted-by":"publisher","first-page":"e1003380","DOI":"10.1371\/journal.pgen.1003380","volume":"9","author":"A Reginensi","year":"2013","unstructured":"Reginensi A, Scott RP, Gregorieff A, Bagherie-Lachidan M, Chung C, Lim DS et al. Yap- and Cdc42-dependent nephrogenesis and morphogenesis during mouse kidney development. PLoS Genet 2013; 9: e1003380.","journal-title":"PLoS Genet"},{"key":"BFcddis201651_CR21","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1038\/nature10137","volume":"474","author":"S Dupont","year":"2011","unstructured":"Dupont S, Morsut L, Aragona M, Enzo E, Giulitti S, Cordenonsi M et al. Role of YAP\/TAZ in mechanotransduction. Nature 2011; 474: 179\u2013183.","journal-title":"Nature"},{"key":"BFcddis201651_CR22","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1038\/nm.1857","volume":"14","author":"C Faul","year":"2008","unstructured":"Faul C, Donnelly M, Merscher-Gomez S, Chang YH, Franz S, Delfgaauw J et al. The actin cytoskeleton of kidney podocytes is a direct target of the antiproteinuric effect of cyclosporine A. Nat Med 2008; 14: 931\u2013938.","journal-title":"Nat Med"},{"key":"BFcddis201651_CR23","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1038\/nm0209-133a","volume":"15","author":"WD Comper","year":"2009","unstructured":"Comper WD . Is the LPS-mediated proteinuria mouse model relevant to human kidney disease? Nat Med 2009; 15: 133 (author reply 133\u2013134).","journal-title":"Nat Med"},{"key":"BFcddis201651_CR24","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1111\/j.1440-1797.2010.01383.x","volume":"16","author":"VW Lee","year":"2011","unstructured":"Lee VW, Harris DC . Adriamycin nephropathy: a model of focal segmental glomerulosclerosis. Nephrology (Carlton) 2011; 16: 30\u201338.","journal-title":"Nephrology (Carlton)"},{"key":"BFcddis201651_CR25","doi-asserted-by":"publisher","first-page":"2142","DOI":"10.1172\/JCI57935","volume":"121","author":"AB Fogo","year":"2011","unstructured":"Fogo AB . The targeted podocyte. J Clin Invest 2011; 121: 2142\u20132145.","journal-title":"J Clin Invest"},{"key":"BFcddis201651_CR26","doi-asserted-by":"publisher","first-page":"1608","DOI":"10.1172\/JCI71195","volume":"124","author":"I Daehn","year":"2014","unstructured":"Daehn I, Casalena G, Zhang T, Shi S, Fenninger F, Barasch N et al. Endothelial mitochondrial oxidative stress determines podocyte depletion in segmental glomerulosclerosis. J Clin Invest 2014; 124: 1608\u20131621.","journal-title":"J Clin Invest"},{"key":"BFcddis201651_CR27","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1038\/nrm2476","volume":"9","author":"SJ Heasman","year":"2008","unstructured":"Heasman SJ, Ridley AJ . Mammalian Rho GTPases: new insights into their functions from in vivo studies. Nat Rev Mol Cell Biol 2008; 9: 690\u2013701.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"BFcddis201651_CR28","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/S0955-0674(97)80156-1","volume":"9","author":"N Tapon","year":"1997","unstructured":"Tapon N, Hall A . Rho, Rac and Cdc42 GTPases regulate the organization of the actin cytoskeleton. Curr Opin Cell Biol 1997; 9: 86\u201392.","journal-title":"Curr Opin Cell Biol"},{"key":"BFcddis201651_CR29","doi-asserted-by":"publisher","first-page":"15362","DOI":"10.1073\/pnas.95.26.15362","volume":"95","author":"L Ma","year":"1998","unstructured":"Ma L, Rohatgi R, Kirschner MW . The Arp2\/3 complex mediates actin polymerization induced by the small GTP-binding protein Cdc42. Proc Natl Acad Sci U S A 1998; 95: 15362\u201315367.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"BFcddis201651_CR30","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/S0092-8674(00)80732-1","volume":"97","author":"R Rohatgi","year":"1999","unstructured":"Rohatgi R, Ma L, Miki H, Lopez M, Kirchhausen T, Takenawa T et al. The interaction between N-WASP and the Arp2\/3 complex links Cdc42-dependent signals to actin assembly. Cell 1999; 97: 221\u2013231.","journal-title":"Cell"},{"key":"BFcddis201651_CR31","doi-asserted-by":"publisher","first-page":"6706","DOI":"10.1128\/MCB.21.19.6706-6717.2001","volume":"21","author":"O Zugasti","year":"2001","unstructured":"Zugasti O, Rul W, Roux P, Peyssonnaux C, Eychene A, Franke TF et al. Raf\u2013MEK\u2013Erk cascade in anoikis is controlled by Rac1 and Cdc42 via Akt. Mol Cell Biol 2001; 21: 6706\u20136717.","journal-title":"Mol Cell Biol"},{"key":"BFcddis201651_CR32","doi-asserted-by":"publisher","first-page":"1927","DOI":"10.1016\/j.cellsig.2008.05.002","volume":"20","author":"S Sinha","year":"2008","unstructured":"Sinha S, Yang W . Cellular signaling for activation of Rho GTPase Cdc42. Cell Signal 2008; 20: 1927\u20131934.","journal-title":"Cell Signal"},{"key":"BFcddis201651_CR33","doi-asserted-by":"publisher","first-page":"415","DOI":"10.2353\/ajpath.2007.070075","volume":"171","author":"E Yanagida-Asanuma","year":"2007","unstructured":"Yanagida-Asanuma E, Asanuma K, Kim K, Donnelly M, Young Choi H, Hyung Chang J et al. Synaptopodin protects against proteinuria by disrupting Cdc42:IRSp53:Mena signaling complexes in kidney podocytes. Am J Pathol 2007; 171: 415\u2013427.","journal-title":"Am J Pathol"},{"key":"BFcddis201651_CR34","doi-asserted-by":"publisher","first-page":"R235","DOI":"10.1016\/S1074-5521(99)80107-0","volume":"6","author":"MF Carlier","year":"1999","unstructured":"Carlier MF, Ducruix A, Pantaloni D . Signalling to actin: the Cdc42-N-WASP-Arp2\/3 connection. Chem Biol 1999; 6: R235\u2013R240.","journal-title":"Chem Biol"},{"key":"BFcddis201651_CR35","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1016\/j.cell.2009.08.049","volume":"139","author":"G Kesavan","year":"2009","unstructured":"Kesavan G, Sand FW, Greiner TU, Johansson JK, Kobberup S, Wu X et al. Cdc42-mediated tubulogenesis controls cell specification. Cell 2009; 139: 791\u2013801.","journal-title":"Cell"},{"key":"BFcddis201651_CR36","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1016\/j.semcdb.2012.05.004","volume":"23","author":"W Hong","year":"2012","unstructured":"Hong W, Guan KL . The YAP and TAZ transcription co-activators: key downstream effectors of the mammalian Hippo pathway. Semin Cell Dev Biol 2012; 23: 785\u2013793.","journal-title":"Semin Cell Dev Biol"},{"key":"BFcddis201651_CR37","doi-asserted-by":"publisher","first-page":"8531","DOI":"10.1074\/jbc.M112.435941","volume":"288","author":"L Hong","year":"2013","unstructured":"Hong L, Kenney SR, Phillips GK, Simpson D, Schroeder CE, Noth J et al. Characterization of a Cdc42 protein inhibitor and its use as a molecular probe. J Biol Chem 2013; 288: 8531\u20138543.","journal-title":"J Biol Chem"},{"key":"BFcddis201651_CR38","doi-asserted-by":"publisher","first-page":"2504","DOI":"10.1016\/j.cellsig.2014.07.031","volume":"26","author":"Y Zhang","year":"2014","unstructured":"Zhang Y, Xia H, Ge X, Chen Q, Yuan D, Chen Q et al. CD44 acts through RhoA to regulate YAP signaling. Cellular signalling 2014; 26: 2504\u20132513.","journal-title":"Cellular signalling"},{"key":"BFcddis201651_CR39","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1006\/excr.1997.3739","volume":"236","author":"P Mundel","year":"1997","unstructured":"Mundel P, Reiser J, Zuniga Mejia Borja A, Pavenstadt H, Davidson GR, Kriz W et al. Rearrangements of the cytoskeleton and cell contacts induce process formation during differentiation of conditionally immortalized mouse podocyte cell lines. Exp Cell Res 1997; 236: 248\u2013258.","journal-title":"Exp Cell Res"},{"key":"BFcddis201651_CR40","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1111\/j.1476-5381.2010.00872.x","volume":"160","author":"C Kilkenny","year":"2010","unstructured":"Kilkenny C, Browne W, Cuthill IC, Emerson M, Altman DG . Animal research: reporting in vivo experiments: the ARRIVE guidelines. Br J Pharmacol 2010; 160: 1577\u20131579.","journal-title":"Br J Pharmacol"},{"key":"BFcddis201651_CR41","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.1038\/ki.2014.428","volume":"87","author":"H Bao","year":"2015","unstructured":"Bao H, Ge Y, Peng A, Gong R . Fine-tuning of NFkappaB by glycogen synthase kinase 3beta directs the fate of glomerular podocytes upon injury. Kidney Int 2015; 87: 1176\u20131190.","journal-title":"Kidney Int"},{"key":"BFcddis201651_CR42","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1002\/eji.200939262","volume":"39","author":"J Lloberas","year":"2009","unstructured":"Lloberas J, Celada A . p21(waf1\/CIP1), a CDK inhibitor and a negative feedback system that controls macrophage activation. Eur J Immunol 2009; 39: 691\u2013694.","journal-title":"Eur J Immunol"},{"key":"BFcddis201651_CR43","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/j.neuroscience.2014.12.059","volume":"289","author":"Y Zhang","year":"2015","unstructured":"Zhang Y, Liu J, Luan G, Wang X . Inhibition of the small GTPase Cdc42 in regulation of epileptic-seizure in rats. Neuroscience 2015; 289: 381\u2013391.","journal-title":"Neuroscience"},{"key":"BFcddis201651_CR44","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1186\/1479-5876-11-295","volume":"11","author":"K Zins","year":"2013","unstructured":"Zins K, Gunawardhana S, Lucas T, Abraham D, Aharinejad S . Targeting Cdc42 with the small molecule drug AZA197 suppresses primary colon cancer growth and prolongs survival in a preclinical mouse xenograft model by downregulation of PAK1 activity. J Transl Med 2013; 11: 295.","journal-title":"J Transl Med"},{"key":"BFcddis201651_CR45","doi-asserted-by":"publisher","first-page":"2475","DOI":"10.1093\/ndt\/gfq750","volume":"26","author":"J Toyonaga","year":"2011","unstructured":"Toyonaga J, Tsuruya K, Ikeda H, Noguchi H, Yotsueda H, Fujisaki K et al. Spironolactone inhibits hyperglycemia-induced podocyte injury by attenuating ROS production. Nephrol Dial Transplant 2011; 26: 2475\u20132484.","journal-title":"Nephrol Dial Transplant"},{"key":"BFcddis201651_CR46","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1111\/bph.12292","volume":"170","author":"L Zhang","year":"2013","unstructured":"Zhang L, Li R, Shi W, Liang X, Liu S, Ye Z et al. NFAT2 inhibitor ameliorates diabetic nephropathy and podocyte injury in db\/db mice. Br J Pharmacol 2013; 170: 426\u2013439.","journal-title":"Br J Pharmacol"},{"key":"BFcddis201651_CR47","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1038\/ki.2012.447","volume":"83","author":"J Si","year":"2013","unstructured":"Si J, Ge Y, Zhuang S, Wang LJ, Chen S, Gong R . Adrenocorticotropic hormone ameliorates acute kidney injury by steroidogenic-dependent and -independent mechanisms. Kidney Int 2013; 83: 635\u2013646.","journal-title":"Kidney Int"}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/cddis201651.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/cddis201651","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/cddis201651.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,4]],"date-time":"2023-01-04T09:05:08Z","timestamp":1672823108000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/cddis201651"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3,17]]},"references-count":47,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2016,3]]}},"alternative-id":["BFcddis201651"],"URL":"https:\/\/doi.org\/10.1038\/cddis.2016.51","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,3,17]]},"assertion":[{"value":"29 October 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 February 2016","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 February 2016","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 March 2016","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}